TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12452517

Group type: EXPERIMENTAL
Intervention: Nizer
Number of subjects: 118

Group type: COMPARATOR
Intervention: Nimesulide
Number of subjects: 118
Study: 10508879

Group type: EXPERIMENTAL
Intervention: Antibiotic therapy
Number of subjects: 268

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 268

Group type: COMPARATOR
Intervention: Control group (preterm labor without pPROM)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Control group (term labor)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Control group (term PROM)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Control group (term cesarean section)
Number of subjects: 268
Study: 7782629

Group type: EXPERIMENTAL
Intervention: Diuretics, vasodilators, cardiac glycosides, and other inotropes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mechanical devices for support of the heart and circulation
Number of subjects: 0
Study: 1773423

Group type: EXPERIMENTAL
Intervention: L-deprenyl
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 6184898

Group type: EXPERIMENTAL
Intervention: Gabexate-mesilate (synthetic protease inhibitor)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Secretin
Number of subjects: 0
Study: 31675175

Group type: EXPERIMENTAL
Intervention: H&E stain
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Rapid Pap stain
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Giemsa stain
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Feulgen stain
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Touch imprint cytology for lymph nodes
Number of subjects: 32
Study: 31801630

Group type: EXPERIMENTAL
Intervention: Functional task exercise group
Number of subjects: 59

Group type: COMPARATOR
Intervention: Cognitive training group
Number of subjects: 59

Group type: COMPARATOR
Intervention: Exercise training group
Number of subjects: 59

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 59
Study: 28342683

Group type: EXPERIMENTAL
Intervention: White grape juice
Number of subjects: 40

Group type: COMPARATOR
Intervention: Apple juice
Number of subjects: 40
Study: 26438129

Group type: EXPERIMENTAL
Intervention: Gold Standard Program (GSP) for smoking cessation intervention
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 32
Study: 23433659

Group type: EXPERIMENTAL
Intervention: Raft-construct outside the plate
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Non-locking raft screws through the plate
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Locking raft screws through the plate
Number of subjects: 3

Group type: COMPARATOR
Intervention: Combined groups using screws through the plate (Groups 2+3)
Number of subjects: 3
Study: 21336159

Group type: EXPERIMENTAL
Intervention: Quadruple eradication and iron supplementation
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Quadruple sequential eradication
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Iron supplementation
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Eradicated infection
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Cytotoxin-associated gene product A negative strains
Number of subjects: 110
Study: 19710072

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Glidescope laryngoscope
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Bonfils fibrescope
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: CTrach intubating laryngeal mask airway
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Non-anaesthetists
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Consultant anaesthetists
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Glidescope
Number of subjects: 63
Study: 16616884

Group type: EXPERIMENTAL
Intervention: 5 min rest break added to every working hour (experimental condition)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (no additional rest breaks)
Number of subjects: 82
Study: 15884476

Group type: EXPERIMENTAL
Intervention: Cryotherapy (frozen gel band)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Acetaminophen
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cryotherapy and Acetaminophen
Number of subjects: 31
Study: 11996608

Group type: EXPERIMENTAL
Intervention: Total cholesterol (upper vs lower tertile)
Number of subjects: 11177

Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein cholesterol (upper vs lower tertile)
Number of subjects: 11177

Group type: EXPERIMENTAL
Intervention: High-density lipoprotein cholesterol (upper vs lower tertile)
Number of subjects: 11177

Group type: EXPERIMENTAL
Intervention: Percentage of serum cholesterol contained in HDL (upper vs lower tertile)
Number of subjects: 11177
Study: 9789769

Group type: EXPERIMENTAL
Intervention: Thermoradiotherapy (TRT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Radiotherapy (RT)
Number of subjects: 72
Study: 7626573

Group type: EXPERIMENTAL
Intervention: Continuous wave diode (810 nm)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Free running neodymium:yttrium aluminium garnet (Nd:YAG) laser (1064 nm)
Number of subjects: 40
Study: 2146634

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (1000 mu g)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Aerosolized placebo
Number of subjects: 11
Study: 363053

Group type: EXPERIMENTAL
Intervention: Netilmicin (2 mg/kg, intramuscularly every 12 h for 7 to 10 days)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Amikacin (7.5 mg/kg, intramuscularly every 12 h for 7 to 10 days)
Number of subjects: 57
Study: 30645696

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Laser treatment
Number of subjects: 100
Study: 28753762

Group type: EXPERIMENTAL
Intervention: Statin use after diagnosis
Number of subjects: 6537

Group type: COMPARATOR
Intervention: Statin use before diagnosis
Number of subjects: 6537
Study: 25864876

Group type: EXPERIMENTAL
Intervention: 6-hour PIRRT sessions (G1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 10-hour PIRRT sessions (G2)
Number of subjects: 75
Study: 23958252

Group type: EXPERIMENTAL
Intervention: Anacetrapib (ANA) 10 mg
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Anacetrapib (ANA) 40 mg
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Anacetrapib (ANA) 100 mg
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Anacetrapib (ANA) 300 mg
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Anacetrapib (ANA) co-administered with atorvastatin (ATV) 10 mg
Number of subjects: 407

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 407
Study: 21829926

Group type: COMPARATOR
Intervention: Version 1 of the sentence list
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All sentence versions
Number of subjects: 120
Study: 19488997

Group type: EXPERIMENTAL
Intervention: Coping skills training (n = 53)
Number of subjects: 82

Group type: COMPARATOR
Intervention: General diabetes education (n = 29)
Number of subjects: 82
Study: 17284629

Group type: EXPERIMENTAL
Intervention: Parathyroidectomy
Number of subjects: 191

Group type: COMPARATOR
Intervention: Medical observation
Number of subjects: 191
Study: 14757293

Group type: EXPERIMENTAL
Intervention: Combination therapy with rosiglitazone (8 mg per day) and glibenclamide (7.5 mg per day)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Glibenclamide monotherapy (up-titration to maximum dose of 15 mg per day)
Number of subjects: 340
Study: 11383790

Group type: EXPERIMENTAL
Intervention: Minimally invasive saphenous vein harvest
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional (open) saphenous vein harvest
Number of subjects: 40
Study: 9401408

Group type: EXPERIMENTAL
Intervention: Elster's polyps
Number of subjects: 31

Group type: COMPARATOR
Intervention: Hyperplastic polyps
Number of subjects: 31

Group type: COMPARATOR
Intervention: Randomly chosen gastric biopsy specimens
Number of subjects: 31
Study: 7968551

Group type: EXPERIMENTAL
Intervention: Angular disparity between objects and angular distance from the vertical axis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Objects rotated in depth
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Searching for matching ends of figures (Experiments 1 and 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Evident matching ends (Experiment 3)
Number of subjects: 0
Study: 3311648

Group type: EXPERIMENTAL
Intervention: Ketanserin (10 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 28560489

Group type: EXPERIMENTAL
Intervention: Broadcast of the Holy Quran with translation
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Broadcast of the Holy Quran without translation
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 168
Study: 29721574

Group type: EXPERIMENTAL
Intervention: Delafloxacin 200 mg
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Delafloxacin 400 mg
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52

Group type: COMPARATOR
Intervention: Lomefloxacin 400 mg
Number of subjects: 52
Study: 28441958

Group type: EXPERIMENTAL
Intervention: Metformin (1700 mg per day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25545821

Group type: EXPERIMENTAL
Intervention: Acetate-free bicarbonate (AF) dialysis fluid
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard acetate-containing bicarbonate (AC) dialysis fluid
Number of subjects: 22
Study: 24044798

Group type: EXPERIMENTAL
Intervention: Breast conserving surgery plus radiotherapy (BCS+RT)
Number of subjects: 9231

Group type: COMPARATOR
Intervention: Mastectomy without radiotherapy (MST-only)
Number of subjects: 9231

Group type: COMPARATOR
Intervention: Mastectomy plus radiotherapy (MST+RT)
Number of subjects: 9231
Study: 20514832

Group type: EXPERIMENTAL
Intervention: Chewing gum (sugarless) for 30 minutes thrice daily until resumption of intestinal transit
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no chewing gum)
Number of subjects: 46
Study: 19031320

Group type: EXPERIMENTAL
Intervention: Quadriceps magnetic stimulation training for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified what the control intervention was)
Number of subjects: 0
Study: 16816481

Group type: EXPERIMENTAL
Intervention: Activated vitamin D(3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 14653296

Group type: EXPERIMENTAL
Intervention: SureFil (non-thermocycled)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: P60 (non-thermocycled)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Amalgam (non-thermocycled)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Solitaire (non-thermocycled)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Z250 (non-thermocycled)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: SureFil (thermocycled)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: P60 (thermocycled)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Amalgam (thermocycled)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Solitaire (thermocycled)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Z250 (thermocycled)
Number of subjects: 60
Study: 11035314

Group type: EXPERIMENTAL
Intervention: Rise in diastolic blood pressure of >/=15 mm Hg with proteinuria
Number of subjects: 4302

Group type: COMPARATOR
Intervention: Normotensive women without a rise in diastolic blood pressure or proteinuria
Number of subjects: 4302
Study: 8831309

Group type: EXPERIMENTAL
Intervention: Propofol plus desflurane in N2O‐O2 (PDN)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Desflurane (induction) plus desflurane in O2 (DD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Propofol plus propofol infusion with N2O‐O2 (PPN)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Propofol plus desflurane in O2 (PD)
Number of subjects: 20
Study: 1454160

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 520

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 520
Study: 6324616

Group type: EXPERIMENTAL
Intervention: Captopril 3 mg/kg po
Number of subjects: 12
Study: 30036193

Group type: EXPERIMENTAL
Intervention: Carbohydrate-restricted diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Energy restriction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smaller studies on carbohydrate restriction
Number of subjects: 0
Study: 26416494

Group type: EXPERIMENTAL
Intervention: Irrigation during incision and drainage
Number of subjects: 209

Group type: COMPARATOR
Intervention: No irrigation during incision and drainage
Number of subjects: 209
Study: 25675566

Group type: EXPERIMENTAL
Intervention: Mild moxibustion at Yaoyangguan (GV 3) under thermosensitive condition
Number of subjects: 57
Study: 22390467

Group type: EXPERIMENTAL
Intervention: Visual associative strategy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verbal associative strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Training with strategies utilizing unaffected cortical regions
Number of subjects: 0
Study: 20518153

Group type: EXPERIMENTAL
Intervention: SSRI antidepressant drugs (e.g., Prozac)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RCTs
Number of subjects: 0
Study: 18333732

Group type: EXPERIMENTAL
Intervention: Interdisciplinary palliative care service (IPCS)
Number of subjects: 517

Group type: COMPARATOR
Intervention: Usual hospital care (UC)
Number of subjects: 517
Study: 15389280

Group type: EXPERIMENTAL
Intervention: High-dose intravenous immunoglobulin (IVIG) 2 g/kg body weight over 2 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Historical cohort (not treated with IVIG)
Number of subjects: 10
Study: 12873543

Group type: EXPERIMENTAL
Intervention: CMV hyperimmune globulin (CMV‐IGIV) prophylaxis
Number of subjects: 44

Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 44
Study: 11135227

Group type: EXPERIMENTAL
Intervention: Intratumoral injection of 30 million autologous dendritic cells (DCs) per tumor after treatment with granulocyte‐macrophage‐colony stimulating factor and interleukin‐4.
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intratumoral injection of dendritic cells (DCs).
Number of subjects: 10
Study: 8982742

Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol 20 micrograms for 10 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ibuprofen 800 mg three times a day for 5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1621773

Group type: EXPERIMENTAL
Intervention: Pilocarpine 2% every 12 hours with nasolacrimal occlusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carbachol 1.5% every 12 hours with nasolacrimal occlusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Timolol with nasolacrimal occlusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Timolol 0.25% and Carbachol 1.5% every 12 hours with nasolacrimal occlusion
Number of subjects: 0
Study: 6239893

Group type: EXPERIMENTAL
Intervention: 5% minoxidil solution
Number of subjects: 16

Group type: COMPARATOR
Intervention: 0%, 1%, 3% minoxidil solutions
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: minoxidil (all concentrations)
Number of subjects: 16
Study: 31324520

Group type: EXPERIMENTAL
Intervention: rhBMP-2
Number of subjects: 400
Study: 29223722

Group type: EXPERIMENTAL
Intervention: Intravenous parecoxib (40 mg diluted in 2 mL, given 30 minutes before surgery and every 12 hours for 48 hours)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (2 mL normal saline given at the same intervals)
Number of subjects: 160
Study: 26920599

Group type: EXPERIMENTAL
Intervention: Aspirin monotherapy
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Oral Anticoagulation (OAC) monotherapy
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Aspirin + Clopidogrel
Number of subjects: 1000

Group type: COMPARATOR
Intervention: OAC + Clopidogrel
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: OAC monotherapy
Number of subjects: 1000
Study: 25300457

Group type: EXPERIMENTAL
Intervention: S.MS self-management training program
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (brochures)
Number of subjects: 64
Study: 22207715

Group type: EXPERIMENTAL
Intervention: Sirolimus
Number of subjects: 103

Group type: COMPARATOR
Intervention: Calcineurin inhibitors (Control)
Number of subjects: 103
Study: 20087377

Group type: EXPERIMENTAL
Intervention: Walnut-supplemented diet (12% of total daily energy intake)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Habitual (control) diet
Number of subjects: 87
Study: 17134774

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study: 11106134

Group type: EXPERIMENTAL
Intervention: Alprazolam SR (1.5 mg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Bromazepam (3 mg taken three times daily)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Lorazepam (1 mg taken three times daily)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 9347095

Group type: EXPERIMENTAL
Intervention: Low dose of alcohol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Nonalcohol beverage (Control)
Number of subjects: 18
Study: 8474819

Group type: EXPERIMENTAL
Intervention: Iron-fortified rice cereal
Number of subjects: 515

Group type: COMPARATOR
Intervention: Unfortified rice cereal
Number of subjects: 515

Group type: COMPARATOR
Intervention: Iron-fortified formula
Number of subjects: 515
Study: 2878030

Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 200

Group type: COMPARATOR
Intervention: Cefotetan
Number of subjects: 200
Study: 30541376

Group type: EXPERIMENTAL
Intervention: Reproductive Life Plan (RLP)‐based counselling
Number of subjects: 201

Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 201
Study: 27500351

Group type: EXPERIMENTAL
Intervention: 2% lidocaine gel
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 24240666

Group type: EXPERIMENTAL
Intervention: Azithromycin (AZM) combined with prednisone
Number of subjects: 211

Group type: COMPARATOR
Intervention: Prednisone alone
Number of subjects: 211
Study: 21497520

Group type: EXPERIMENTAL
Intervention: Peer education (PE)
Number of subjects: 118
Study: 20545477

Group type: EXPERIMENTAL
Intervention: Multimedia instructional video about MPS with supplemental handouts
Number of subjects: 62

Group type: COMPARATOR
Intervention: Trigger-point dry needling and muscle-stretch exercise regimen
Number of subjects: 62
Study: 18751497

Group type: EXPERIMENTAL
Intervention: Amlodipine besylate test formulation (10 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Amlodipine besylate reference formulation (10 mg)
Number of subjects: 24
Study: 15973092

Group type: EXPERIMENTAL
Intervention: Injection-model training with instructional videotape and visual feedback on injection accuracy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group studying technical aspects of injections
Number of subjects: 30
Study: 12795748

Group type: EXPERIMENTAL
Intervention: Furazolidone 2 x 200 mg + amoxycillin 2 x 1 g + omeprazole 2 x 20 mg/day
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Furazolidone 2 x 50 mg + amoxycillin 2 x 1 g + omeprazole 2 x 20 mg/day
Number of subjects: 123
Study: 10381910

Group type: EXPERIMENTAL
Intervention: rhIL‐11 40 microgram. kg‐1. wk‐1 (2 or 5 times weekly for 3 weeks)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: rhIL‐11 16 microgram. kg‐1. wk‐1 (5 times weekly for 3 weeks)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: rhIL‐11 16 microgram. kg‐1. wk‐1 (2 times weekly for 3 weeks)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 8532271

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (100 mg/day)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Abnormal uterine artery flow velocity waveforms
Number of subjects: 186
Study: 1669669

Group type: EXPERIMENTAL
Intervention: Taurine (30 mg/kg per day)
Number of subjects: 13
Study: 29676592

Group type: EXPERIMENTAL
Intervention: Pulsed-dye laser (PDL) treatment every four weeks for four months
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (untreated lesions)
Number of subjects: 9
Study: 28573748

Group type: EXPERIMENTAL
Intervention: Conditioned pain modulation (CPM) using noxious cold (6 °C) water before thermal grill application.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control run with 33 °C water.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental group rated pain and unpleasantness of a thermal grill with innocuous alternating warm (42 °C) and cool (18 °C) bars.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group rated a grill with all bars controlled to a noxious temperature (45 °C).
Number of subjects: 0
Study: 25945550

Group type: EXPERIMENTAL
Intervention: Transcranial bright light (TBL) treatment; administered as intermittent light exposures (4 × 12 min) during the 7-day post-travel period after an eastward transatlantic flight.
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo treatment; details not specified.
Number of subjects: 55
Study: 23322564

Group type: EXPERIMENTAL
Intervention: Plasma exchange (PLEX) treatment
Number of subjects: 42

Group type: COMPARATOR
Intervention: Intravenous immunoglobulin (IVIg)
Number of subjects: 42
Study: 21293964

Group type: EXPERIMENTAL
Intervention: Lower Body Negative Pressure (LBNP)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Microgravity
Number of subjects: 1

Group type: COMPARATOR
Intervention: Pre-flight condition
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Post-flight condition
Number of subjects: 1
Study: 19627273

Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 337

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 337
Study: 18046594

Group type: EXPERIMENTAL
Intervention: Very Low Carbohydrate Diet (VLCKD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low Fat Diet (LFD)
Number of subjects: 0
Study: 15943939

Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine (4-24 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Oral methadone (20-100 mg)
Number of subjects: 21
Study: 11883347

Group type: EXPERIMENTAL
Intervention: Spontaneous delivery of the placenta (group 1)
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Manual removal of the placenta (group 2)
Number of subjects: 375